Spex Capital
All figures cover the European funds tracked here since 1 January 2025, whether closed or still raising, and are compiled from public sources.
- Tracked funds
- 1
- Reported volume
- €30m
- Latest public closing
- 14 Oct 2025
Reported volume sums the public fund amounts tracked here, not the manager's firm-wide assets under management, so it may differ from totals on the manager's website.
London-based early-stage venture capital firm investing in digital health and medtech.
Focus: Early-stage digital health and medtech ventures, including technologies to improve healthcare delivery globally
14 October 2025: Spex Capital reported €30m of commitments for its Venture HealthTech Fund against a €100m target (EU-Startups, Tech Funding News).
Tracked funds
FundStageHQAs ofAmount €M
- 30.0
Seed to Series A in digital health and medical technology.
- Health & Bio
- UK and Europe
- 14 Oct 2025
- Spex Capital